Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, +4966

The Lancet

Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial +5

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, +4969

The Lancet

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, +4973

The Lancet

Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine +1

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, +4972

The Lancet

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani, +351

The Lancet Infectious Diseases

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD

Mona Bafadhel, Tristan Clark, Carlene Reid, +5

CHEST Journal

InflammationAsthmaCommunity-acquired PneumoniaAllergyHospitalized Adult Patients +4

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack, +397

˜The œLancet. Gastroenterology & hepatology

HepatologyPretreatment PredictionBiliary TractGastroenterologyPrimary Sclerosing Cholangitis +5

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, +4972

The Lancet

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

Karl G. Nicholson, Keith R. Abrams, Sally Batham, +8

The Lancet Infectious Diseases

VaccinationVaccine SafetyTwo-dose ScheduleImmunologyHead-to-head Trial +7

Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample

Tristan Clark, Marie-Jo Medina, Sally Batham, +3

Journal of Infection